SINGAPORE, 5 MAY 2010 Global IT services provider HCL Technologies (HCL) has signed a five-year, US$500 million strategic engagement with MSD, a global research-driven pharmaceutical company.
MSD is also known as Merck & Co. with headquarters in Whitehouse Station, New Jersey, US.
According to HCL, it will extend its existing relationship with MSD, dating back to 2004, to become an integral business and technology services partner. HCL will provide a multitude of services to MSD, including software-led IT solutions, remote infrastructure management, engineering and business and knowledge process services.
The pharmaceutical company will leverage HCL's near-shore delivery network in the US comprised of its operations centre in Raleigh, North Carolina, and its global data centre delivery ecosystem, said an HCL spokesperson.
For five years, MSD has leveraged HCL's extensive expertise in life sciences and healthcare to streamline operational efficiencies and consolidate its IT portfolio, said Richard G. Branton, vice president of application services, MSD. "As we continue to leverage global delivery services to meet our business imperatives, we have chosen HCL as our strategic partner for its depth of technology and pharmaceutical domain experience, coupled with its flexibility to engage and a commitment to deliver.
For HCL, this is one of the largest strategic engagements in the company's history. As a result of this engagement, HCL will expand its US team in North Carolina, relying on staff hired locally for projects, thus creating jobs for the local community. In total, HCL will deliver services out of 20 worldwide locations including the US, Poland, China and Brazil.
Sign up for CIO Asia eNewsletters.